{"chain_id": "chain_000000", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "21519338", "num_turns": 4, "model": "gpt-4o-mini", "all_correct": true, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 21519338, is the following pharmacogenomic claim supported or contradicted: Allele A is not associated with clearance of olanzapine in people with Schizophrenia as compared to allele G. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Contradicted.", "correct": true}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical association.", "correct": true}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 981479838 (PMID 21519338)?", "answer": 235, "response": "The study reports a total of 235 cases.", "correct": true}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True.", "correct": true}]}
{"chain_id": "chain_000001", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "20450993", "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 20450993, is the following pharmacogenomic claim supported or contradicted: Genotype TT is associated with increased bone mineral density as compared to genotypes CC + CT. Answer one of: supported, contradicted.", "answer": "supported", "response": "The claim is contradicted. The study indicates that the TT genotype (associated with the rs12503796 polymorphism) results in decreased expression of FGFBP1 and inhibits upregulation of the gene by testosterone, which suggests that this genotype would not be associated with increased bone mineral density compared to the CC + CT genotypes.", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "The annotation represents a functional assay. The study includes in vitro functional studies demonstrating the effects of the rs12503796 polymorphism on FGFBP1 expression and its response to testosterone.", "correct": false}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 769163232 (PMID 20450993)?", "answer": 972, "response": "The study reports a total of 872 cases in the Mexican American cohort and 972 cases in the Amish replication cohort.", "correct": true}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True. Both cohorts exceed the minimum requirement of N \u2265 30 for study cases.", "correct": true}]}
{"chain_id": "chain_000002", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "24729586", "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24729586, is the following pharmacogenomic claim supported or contradicted: Allele C is associated with metabolism of efavirenz in people with HIV Infections as compared to allele T. Answer one of: supported, contradicted.", "answer": "supported", "response": "The claim is supported. The study found that the CYP2A6 -48T\u2192G polymorphism (where allele G is associated with increased efavirenz concentrations) indicates that allele C (in the context of CYP2B6 983T\u2192C) is associated with higher efavirenz concentrations compared to allele T in individuals with a CYP2B6 slow metabolizer genotype.", "correct": true}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "The annotation represents a clinical association.", "correct": true}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1184467544 (PMID 24729586) for this association?", "answer": "= 0.004", "response": "The reported p-value for the association with CYP2A6 -48T\u2192G is 3.8 \u00d7 10^\u22124.", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": true, "response": "True.", "correct": true}]}
{"chain_id": "chain_000003", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "32504053", "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 32504053, is the following pharmacogenomic claim supported or contradicted: Allele T is not associated with risk of Hypoglycemia when treated with glibenclamide, glimepiride or glipizide in people with Diabetes Mellitus, Type 2 as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "The claim is supported. The study found no evidence of association between the *CYP2C9* reduced function alleles and the risk of hypoglycemia in patients treated with sulfonylureas, including glibenclamide, glimepiride, or glipizide.", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "The annotation represents a clinical association.", "correct": true}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1451412926 (PMID 32504053)?", "answer": 356, "response": "In the study reported in PMID 32504053, there are 356 cases identified.", "correct": true}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True. The dataset minimum of N \u2265 30 for study cases is met, as there are 356 cases reported.", "correct": true}]}
{"chain_id": "chain_000004", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "26463708", "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 26463708, is the following pharmacogenomic claim supported or contradicted: Allele A is associated with decreased concentrations of triglycerides in women with Breast Neoplasms and Menopause as compared to allele G. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported.", "correct": true}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical association.", "correct": true}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1447677223 (PMID 26463708)?", "answer": 160, "response": "A total of 303 women had complete genetic and lipid data and were evaluable for analysis in the study.", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True.", "correct": true}]}
{"chain_id": "chain_000005", "chain_family": "B_claim\u2192presence_absence", "pmid": "27747906", "num_turns": 2, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 27747906, is the following pharmacogenomic claim supported, contradicted, or not reported: Genotypes AG + GG is not associated with Recurrence free survival when treated with hdl cholesterol in women with Breast Neoplasms as compared to genotype AA. Answer one of: supported, contradicted, not_reported.", "answer": "not_reported", "response": "Not reported.", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "Does PMID 27747906 report any quantitative statistic (p-value/OR/CI) for this claim?", "answer": "no", "response": "No, PMID 27747906 does not report any quantitative statistics (p-value, odds ratio, or confidence interval) specifically for the claim regarding genotypes AG + GG not being associated with recurrence-free survival when treated with HDL cholesterol in women with breast neoplasms. The study focuses on the association of specific SNPs in the CYP19A1 gene with cancer recurrence, but does not provide data for the mentioned genotypes or treatment.", "correct": true}]}
{"chain_id": "chain_000006", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "29100455", "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 29100455, is the following pharmacogenomic claim supported or contradicted: Allele G is not associated with likelihood of Leukopenia and Neutropenia when treated with cyclophosphamide, epirubicin and fluorouracil in women with Breast Neoplasms as compared to allele A. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "The claim is supported. The study found that none of the SNPs, including those associated with allele G, were predictive for leukopenia or neutropenia during treatment with docetaxel/gemcitabine, and specifically noted that genetic variance in the PIGB gene did not correlate with hematotoxicity after FEC chemotherapy.", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "The annotation represents a clinical association.", "correct": true}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many cases are reported in Study Parameters 1448624317 (PMID 29100455)?", "answer": 2678, "response": "In the study reported in PMID 29100455, a total of 1,678 patients were included in the analysis for predicting chemotherapy-induced grade 3 or grade 4 neutropenia.", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study cases? Answer true or false.", "answer": true, "response": "True. The dataset meets the minimum requirement of N \u2265 30 for study cases, as it includes 1,678 patients.", "correct": true}]}
{"chain_id": "chain_000007", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "22450926", "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 22450926, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with decreased likelihood of treatment inefficacy when treated with methotrexate in people with Arthritis, Rheumatoid as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "Supported.", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical association.", "correct": true}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What OR is reported in Study Parameters 827863192 (PMID 22450926)?", "answer": "0.54", "response": "The odds ratio (OR) reported for the SNP rs3821353 in the ATIC gene, which is associated with a good response to methotrexate, is 0.51 (95% CI 0.31-0.84).", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does the confidence interval for the OR exclude the null value of 1.0? Answer true or false.", "answer": false, "response": "True.", "correct": false}]}
{"chain_id": "chain_000008", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "24498053", "num_turns": 4, "model": "gpt-4o-mini", "all_correct": true, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 24498053, is the following pharmacogenomic claim supported or contradicted: Allele T is associated with increased risk of Heroin Dependence when exposed to heroin as compared to allele C. Answer one of: supported, contradicted.", "answer": "supported", "response": "Supported.", "correct": true}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "Clinical association.", "correct": true}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "How many controls are reported in Study Parameters 1184221727 (PMID 24498053)?", "answer": 619, "response": "There are 619 controls reported in the study.", "correct": true}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Does this meet the dataset minimum of N \u2265 30 for study controls? Answer true or false.", "answer": true, "response": "True.", "correct": true}]}
{"chain_id": "chain_000009", "chain_family": "A_claim\u2192modality\u2192stat\u2192eval", "pmid": "28283692", "num_turns": 4, "model": "gpt-4o-mini", "all_correct": false, "turns": [{"turn": 1, "reasoning_type": "claim_verification", "question": "Based on PMID 28283692, is the following pharmacogenomic claim supported or contradicted: Allele T is not associated with dose of selumetinib in healthy individuals as compared to allele C. Answer one of: supported, contradicted.", "answer": "contradicted", "response": "The claim is supported. The study found no significant association between the genetic variants in the *CYP2C19*, *UGT1A1*, and *ABCG2* genes and the pharmacokinetics of selumetinib, indicating that allele T is not associated with the dose of selumetinib compared to allele C.", "correct": false}, {"turn": 2, "reasoning_type": "evidence_provenance_localization", "question": "What type of evidence does this annotation represent: clinical association or functional assay? Answer one of: clinical_association, functional_assay.", "answer": "clinical_association", "response": "The annotation represents a clinical association.", "correct": true}, {"turn": 3, "reasoning_type": "statistical_extraction", "question": "What p-value is reported in Study Parameters 1448613493 (PMID 28283692) for this association?", "answer": "= 0.557", "response": "The study reported a p-value below 0.008 for the association between the genetic variants and dose-normalized values for AUC, AUC_0\u201312, or C_max_, after accounting for multiple testing.", "correct": false}, {"turn": 4, "reasoning_type": "objective_evaluation", "question": "Is this finding statistically significant at alpha = 0.05? Answer true or false.", "answer": false, "response": "True.", "correct": false}]}
